Global investment in AI startups from January – June 2025 far outpaced H1 2024. Q1 2025 alone absorbed an estimated $60 – $73 billion, already more than half of 2024’s full-year total and driving a >100 % year-over-year surge. AI companies captured roughly 58 % of all venture dollars in Q1 versus ~28 % a year earlier—clear evidence of investor “AI FOMO.”
Implication: Capital is concentrating in AI at an unprecedented scale, likely reshaping H2 allocations as firms double-down on perceived AI winners.
Outsized later-stage rounds for foundation-model leaders defined the period. OpenAI’s $40 billion raise in March (the largest private round ever) valued it at $300 billion, while Anthropic’s $3.5 billion Series E put it at $61.5 billion. A handful of additional deals—e.g., Safe Superintelligence ($2 billion) and Neuralink ($650 million Series E)—further skewed totals.
Implication: A “winners-take-most” dynamic is funneling the bulk of funding to a very small cohort, soaking up capital that might otherwise flow to earlier-stage or smaller firms.
Beyond the headline mega-rounds, mid-sized deals proliferated while seed activity remained selective. Median AI seed rounds reached ~$15 million (average ~$41 million), and median Series A hit ~$75 – $80 million—both well above historical norms (global median Series A across sectors was ~$10 million in 2022). Growth-stage medians for Series C/D clustered around $250 – $300 million, with averages distorted upward by outliers like OpenAI.
Implication: Deal-size inflation reflects fierce competition for category leaders. Investors unable to write nine-figure checks may pivot to niche plays or earlier stages, while any startup flashing an AI story commanded larger rounds and valuations.
Generative AI and core model/infrastructure players absorbed $45 + billion—over 95 % of disclosed dollars—in H1. Applied-AI verticals were relatively starved (health/biotech ~$0.7 billion; fintech/enterprise ~$2 – $3 billion). Geographically, the U.S. (especially Silicon Valley) dominated: >99 % of H1 AI funding by value went to Americas-headquartered companies. Asia and Europe lagged—China’s largest deal (Zhipu AI) raised $247 million, and Europe saw only mid-sized rounds (e.g., UK’s Latent Labs at $50 million).
Implication: The boom is highly U.S.-centric and led by a few big players; expect non-U.S. governments and investors to respond in H2 with national AI funds, incentives, or cross-border capital to avoid falling behind.
Despite record capital deployment, investor discipline is resurfacing. Many H1 rounds featured strategic or corporate backers (cloud providers, chipmakers, defense primes), signaling a tilt toward tangible use-cases and strategic synergies. Heading into H2, investors will watch how mega-funded startups execute—product delivery, revenue, regulatory navigation—amid intensifying competition.
Implication: H2 capital is likely to favor firms demonstrating efficiency and real market traction—particularly “picks-and-shovels” providers (tools, chips, enterprise software)—raising the bar for newcomers and reinforcing incumbent advantages while challenging fresh entrants.
The first half of 2025 represents a make-or-break moment for the AI investment thesis. The flood of capital into AI now (and its skew toward a few players and regions) will shape the innovation landscape and competitive dynamics for years. For investors, understanding where the money is going – and why – is critical for navigating H2 2025. Will the winners justify their valuations, or will we see a pullback and refocus? The data from H1 provides early clues, informing portfolio strategy, policy considerations (like antitrust and national-security concerns), and founders’ fundraising prospects in the next half-year.
The most interesting funding rounds in the AI sector over the past month.
Governments are still figuring out how to handle AI. In the EU, the AI Act may be finalized by the end of 2025. Expect lobbying wars and possibly early compliance signals from startups in H2. In the U.S., Biden’s executive orders on AI and any movement in Congress—hearings, proposed legislation—will be critical. Emerging rules around data usage, model transparency, or chip export controls could reshape startup economics and investor confidence.
Despite 2025’s private funding surge, we’ve yet to see a breakout AI IPO. This might change in H2. Names like Databricks, Stripe (AI-adjacent), or even OpenAI are floating as potential IPO candidates.
We’re expecting big reveals: possibly OpenAI’s next-gen model or hardware debuts from the Sam Altman/Jony Ive collaboration.
If governments or the public feel AI is out of control, expect rapid interventions: licensing schemes, GDPR-enforced fines, or hard restrictions on certain models.
AI’s lifeblood—GPUs and elite engineers—remains scarce.
Ironically, the LLM race is driving rapid commoditization. Open-source releases (Meta’s LLaMA, Mistral, etc.) blur differentiation.
1.Funding Moderates, But Remains Elevated
Post-H1 euphoria, deal pace will cool. We don’t expect another $40B round, but quarterly AI funding will still double 2024 levels.
The boom continues—just more measured.
2.One Major Liquidity Event Hits
Expect at least one $10B+ exit: IPO (e.g., Databricks) or a mega-acquisition by a legacy player trying to stay relevant.
This will shape investor mood and reset pricing expectations.
3.Clear Stratification in the Startup Ecosystem
By Q4, the split will be obvious:
The next six months will stress test the AI narrative.
Is 2025 the start of a sustained revolution, or a bubble needing correction?
Our view: Some froth will burn off, but the core thesis holds. AI remains the most compelling frontier in venture—just expect more discipline in how the capital flows.
Global investment in AI startups from January – June 2025 far outpaced H1 2024. Q1 2025 alone absorbed an estimated $60 – $73 billion, already more than half of 2024’s full-year total and driving a >100 % year-over-year surge. AI companies captured roughly 58 % of all venture dollars in Q1 versus ~28 % a year earlier—clear evidence of investor “AI FOMO.”
Implication: Capital is concentrating in AI at an unprecedented scale, likely reshaping H2 allocations as firms double-down on perceived AI winners.
Outsized later-stage rounds for foundation-model leaders defined the period. OpenAI’s $40 billion raise in March (the largest private round ever) valued it at $300 billion, while Anthropic’s $3.5 billion Series E put it at $61.5 billion. A handful of additional deals—e.g., Safe Superintelligence ($2 billion) and Neuralink ($650 million Series E)—further skewed totals.
Implication: A “winners-take-most” dynamic is funneling the bulk of funding to a very small cohort, soaking up capital that might otherwise flow to earlier-stage or smaller firms.
Beyond the headline mega-rounds, mid-sized deals proliferated while seed activity remained selective. Median AI seed rounds reached ~$15 million (average ~$41 million), and median Series A hit ~$75 – $80 million—both well above historical norms (global median Series A across sectors was ~$10 million in 2022). Growth-stage medians for Series C/D clustered around $250 – $300 million, with averages distorted upward by outliers like OpenAI.
Implication: Deal-size inflation reflects fierce competition for category leaders. Investors unable to write nine-figure checks may pivot to niche plays or earlier stages, while any startup flashing an AI story commanded larger rounds and valuations.
Generative AI and core model/infrastructure players absorbed $45 + billion—over 95 % of disclosed dollars—in H1. Applied-AI verticals were relatively starved (health/biotech ~$0.7 billion; fintech/enterprise ~$2 – $3 billion). Geographically, the U.S. (especially Silicon Valley) dominated: >99 % of H1 AI funding by value went to Americas-headquartered companies. Asia and Europe lagged—China’s largest deal (Zhipu AI) raised $247 million, and Europe saw only mid-sized rounds (e.g., UK’s Latent Labs at $50 million).
Implication: The boom is highly U.S.-centric and led by a few big players; expect non-U.S. governments and investors to respond in H2 with national AI funds, incentives, or cross-border capital to avoid falling behind.
Despite record capital deployment, investor discipline is resurfacing. Many H1 rounds featured strategic or corporate backers (cloud providers, chipmakers, defense primes), signaling a tilt toward tangible use-cases and strategic synergies. Heading into H2, investors will watch how mega-funded startups execute—product delivery, revenue, regulatory navigation—amid intensifying competition.
Implication: H2 capital is likely to favor firms demonstrating efficiency and real market traction—particularly “picks-and-shovels” providers (tools, chips, enterprise software)—raising the bar for newcomers and reinforcing incumbent advantages while challenging fresh entrants.
The first half of 2025 represents a make-or-break moment for the AI investment thesis. The flood of capital into AI now (and its skew toward a few players and regions) will shape the innovation landscape and competitive dynamics for years. For investors, understanding where the money is going – and why – is critical for navigating H2 2025. Will the winners justify their valuations, or will we see a pullback and refocus? The data from H1 provides early clues, informing portfolio strategy, policy considerations (like antitrust and national-security concerns), and founders’ fundraising prospects in the next half-year.
The most interesting funding rounds in the AI sector over the past month.
Governments are still figuring out how to handle AI. In the EU, the AI Act may be finalized by the end of 2025. Expect lobbying wars and possibly early compliance signals from startups in H2. In the U.S., Biden’s executive orders on AI and any movement in Congress—hearings, proposed legislation—will be critical. Emerging rules around data usage, model transparency, or chip export controls could reshape startup economics and investor confidence.
Despite 2025’s private funding surge, we’ve yet to see a breakout AI IPO. This might change in H2. Names like Databricks, Stripe (AI-adjacent), or even OpenAI are floating as potential IPO candidates.
We’re expecting big reveals: possibly OpenAI’s next-gen model or hardware debuts from the Sam Altman/Jony Ive collaboration.
If governments or the public feel AI is out of control, expect rapid interventions: licensing schemes, GDPR-enforced fines, or hard restrictions on certain models.
AI’s lifeblood—GPUs and elite engineers—remains scarce.
Ironically, the LLM race is driving rapid commoditization. Open-source releases (Meta’s LLaMA, Mistral, etc.) blur differentiation.
1.Funding Moderates, But Remains Elevated
Post-H1 euphoria, deal pace will cool. We don’t expect another $40B round, but quarterly AI funding will still double 2024 levels.
The boom continues—just more measured.
2.One Major Liquidity Event Hits
Expect at least one $10B+ exit: IPO (e.g., Databricks) or a mega-acquisition by a legacy player trying to stay relevant.
This will shape investor mood and reset pricing expectations.
3.Clear Stratification in the Startup Ecosystem
By Q4, the split will be obvious:
The next six months will stress test the AI narrative.
Is 2025 the start of a sustained revolution, or a bubble needing correction?
Our view: Some froth will burn off, but the core thesis holds. AI remains the most compelling frontier in venture—just expect more discipline in how the capital flows.